JP2013510169A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013510169A5 JP2013510169A5 JP2012538031A JP2012538031A JP2013510169A5 JP 2013510169 A5 JP2013510169 A5 JP 2013510169A5 JP 2012538031 A JP2012538031 A JP 2012538031A JP 2012538031 A JP2012538031 A JP 2012538031A JP 2013510169 A5 JP2013510169 A5 JP 2013510169A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- amount
- domain
- compound
- fusion protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003097 Mucus Anatomy 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 102000037240 fusion proteins Human genes 0.000 claims 3
- 108020001507 fusion proteins Proteins 0.000 claims 3
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 2
- 102000005348 Neuraminidase Human genes 0.000 claims 2
- 108010006232 Neuraminidase Proteins 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 230000003197 catalytic Effects 0.000 claims 2
- 210000002345 respiratory system Anatomy 0.000 claims 2
- 102000007299 Amphiregulin Human genes 0.000 claims 1
- 108010033760 Amphiregulin Proteins 0.000 claims 1
Claims (1)
- 対象の呼吸器管における粘液量又は粘液レベルを低下させる、又は粘液量又は粘液レベルの上昇を防止する方法において:
前記対象に治療的有効量の融合タンパク質を含む化合物又は組成物を投与するステップを具え、
前記融合タンパク質が、シアリダーゼの少なくとも一の触媒ドメインを具え、当該シアリダーゼの触媒ドメインが、SEQ ID No.12のアミノ酸274乃至アミノ酸666から伸長したアミノ酸配列と、両立的に、少なくとも一のアンカードメインであって、当該アンカードメインが、SEQ ID No.7のアミノ酸配列を含むヒトアンフィレグリンのグリコサミノグリカン(GAG)結合ドメインである、アンカードメインを含み;
前記治療的有効量が、前記化合物又は組成物を投与する前の粘液量に比べて、前記化合物又は組成物を投与した後に前記呼吸器管の粘液量を低減させる量の融合タンパク質を含む;
ことを特徴とする方法。
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25905509P | 2009-11-06 | 2009-11-06 | |
US25903309P | 2009-11-06 | 2009-11-06 | |
US61/259,033 | 2009-11-06 | ||
US61/259,055 | 2009-11-06 | ||
US32281310P | 2010-04-09 | 2010-04-09 | |
US61/322,813 | 2010-04-09 | ||
US33206310P | 2010-05-06 | 2010-05-06 | |
US61/332,063 | 2010-05-06 | ||
US38142010P | 2010-09-09 | 2010-09-09 | |
US61/381,420 | 2010-09-09 | ||
PCT/US2010/055636 WO2011057081A1 (en) | 2009-11-06 | 2010-11-05 | Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013510169A JP2013510169A (ja) | 2013-03-21 |
JP2013510169A5 true JP2013510169A5 (ja) | 2013-12-26 |
Family
ID=43970356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012538031A Pending JP2013510169A (ja) | 2009-11-06 | 2010-11-05 | 呼吸器管の治療及び予防のための方法、化合物、及び組成物 |
Country Status (8)
Country | Link |
---|---|
US (6) | US8398971B2 (ja) |
EP (1) | EP2496251A4 (ja) |
JP (1) | JP2013510169A (ja) |
CN (1) | CN102711807A (ja) |
AU (1) | AU2010315024B2 (ja) |
CA (1) | CA2780193A1 (ja) |
IL (1) | IL219579B (ja) |
WO (1) | WO2011057081A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8512710B2 (en) | 2002-11-22 | 2013-08-20 | Ansun Biopharma, Inc. | Class of therapeutic protein based molecules |
JP2013510169A (ja) * | 2009-11-06 | 2013-03-21 | ネクスバイオ,インク. | 呼吸器管の治療及び予防のための方法、化合物、及び組成物 |
CA2864746A1 (en) * | 2012-02-17 | 2013-08-22 | Ansun Biopharma, Inc. | Methods, compounds and compositions for treatment of influenza and parainfluenza patients |
EP2866792A4 (en) * | 2012-06-28 | 2016-08-17 | Ansun Biopharma Inc | MICROPARTICLE FORMULATIONS FOR DELIVERY TO LOWER AND CENTRAL RESPIRATORY PATHS AND METHOD OF PREPARING THEM |
EP2877204A2 (en) * | 2012-06-28 | 2015-06-03 | Ansun Biopharma, Inc. | Microparticle formulations for delivery to the upper and central respiratory tract and methods of manufacture |
FR3022256B1 (fr) * | 2014-06-17 | 2018-03-09 | Adisseo France S.A.S. | Nouvelles souches d’arthrobacter gandavensis |
EP4218802A3 (en) | 2016-07-01 | 2023-09-27 | The Board of Trustees of the Leland Stanford Junior University | Conjugates for targeted cell surface editing |
CN108926707B (zh) * | 2017-05-26 | 2021-12-03 | 中国医学科学院病原生物学研究所 | Pf4的抗rsv应用 |
MX2020007024A (es) | 2018-01-03 | 2020-10-28 | Palleon Pharmaceuticals Inc | Sialidasas humanas recombinantes, proteinas de fusion de sialidasa y metodos para usar las mismas. |
CN109288114A (zh) * | 2018-10-08 | 2019-02-01 | 厦门艾赛生物科技有限公司 | 一种唾液酸及其衍生物的应用和唾液酸电子烟液 |
AU2020301037A1 (en) * | 2019-07-03 | 2022-02-03 | Palleon Pharmaceuticals Inc. | Recombinant human sialidases, sialidase fusion proteins, and methods of using the same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7019A (en) * | 1850-01-15 | Improvement in obstetrical supporters | ||
US8501911B2 (en) * | 1999-02-24 | 2013-08-06 | Biomarck Pharmaceuticals, Ltd | Methods of reducing inflammation and mucus hypersecretion |
US7807174B2 (en) * | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
EP1981483A1 (en) * | 2006-01-24 | 2008-10-22 | Nexbio, Inc. | Technology for preparation of macromolecular microspheres |
CA2692892A1 (en) * | 2007-07-24 | 2009-01-29 | Michael Malakhov | Technology for the preparation of microparticles |
AU2008345034A1 (en) * | 2007-12-27 | 2009-07-09 | Aires Pharmaceuticals, Inc. | Aerosolized nitrite and nitric oxide - donating compounds and uses thereof |
JP2013510169A (ja) * | 2009-11-06 | 2013-03-21 | ネクスバイオ,インク. | 呼吸器管の治療及び予防のための方法、化合物、及び組成物 |
-
2010
- 2010-11-05 JP JP2012538031A patent/JP2013510169A/ja active Pending
- 2010-11-05 US US12/940,742 patent/US8398971B2/en active Active
- 2010-11-05 CA CA2780193A patent/CA2780193A1/en not_active Abandoned
- 2010-11-05 AU AU2010315024A patent/AU2010315024B2/en not_active Ceased
- 2010-11-05 EP EP10829154.3A patent/EP2496251A4/en not_active Withdrawn
- 2010-11-05 CN CN2010800606702A patent/CN102711807A/zh active Pending
- 2010-11-05 WO PCT/US2010/055636 patent/WO2011057081A1/en active Application Filing
-
2012
- 2012-05-03 IL IL219579A patent/IL219579B/en active IP Right Grant
-
2013
- 2013-02-15 US US13/769,095 patent/US20130156703A1/en not_active Abandoned
-
2014
- 2014-09-17 US US14/489,428 patent/US20150017150A1/en not_active Abandoned
-
2016
- 2016-04-22 US US15/136,751 patent/US20160228518A1/en not_active Abandoned
-
2018
- 2018-01-08 US US15/865,217 patent/US20180140683A1/en not_active Abandoned
-
2020
- 2020-06-04 US US16/893,265 patent/US20200297822A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2013510169A5 (ja) | ||
EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
JP2015517489A5 (ja) | ||
JP2008530245A5 (ja) | ||
JP2009537143A5 (ja) | ||
WO2010062688A3 (en) | Dosage form for insertion into the mouth | |
JP2008529558A5 (ja) | ||
WO2008151235A3 (en) | Compositions for delivering medicaments into the lungs, uses thereof | |
NZ624873A (en) | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition | |
JP2009517473A5 (ja) | ||
MX340541B (es) | Secuencias de aminoacidos mejoradas dirigidas contra virus sincitial respiratorio humano y polipeptidos que comprenden las mismas para la prevencion y/o tratamiento de infecciones del tracto respiratorio. | |
MX2012001882A (es) | Anticuerpos contra el virus sincitial respiratorio (rsv) humano y metodos de uso. | |
GB2496794A (en) | Combination pharmaceutical composition and methods of treating and methods of treating functional diseases or conditions of gastrointestinal tract | |
JP2013127002A5 (ja) | ||
WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
JP2012500090A5 (ja) | ||
JP2011528895A5 (ja) | ||
WO2007092563A3 (en) | Gene therapy for niemann-pick disease type a | |
WO2008064299A3 (en) | Methods of reducing porcine circovirus-associated disease outbreaks | |
EA201490377A1 (ru) | Лечение рассеянного склероза комбинацией лаквинимода и глатирамера ацетата | |
JP2011528897A5 (ja) | ||
JP2013526392A5 (ja) | ||
UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
JP2014503593A5 (ja) | ||
JP2011225596A5 (ja) |